Special items: Ovarian Cancer and Us blog best viewed in Firefox

Saturday, June 20, 2009

Efficacy of pegylated liposomal doxorubicin (PLD) plus carboplatin in ovarian cancer patients who recur within six to twelve months: A phase II study

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.